BioSpace News Archive

Encouraging results from a study of its MosaiQ™ multiplex molecular disease screening (MDS) Microarray MDS product progressing through development Update regarding progress on the Company’s MosaiQ expanded Immunohematology (IH) microarray Commercial launch of Expanded IH together with already CE marked Initial SDS on track to be launched in Europe around year-end 2021

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the first quarter of 2021 and provided updated revenue guidance for the full-year 2021. The Company also provided additional information regarding the expected financial impact of 7D Surgical in 2021 and 2022.

XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has commenced an underwritten registered public offering of depositary shares, each representing 1/1000 th fractional interest in a share of the Company’s Series B Cumulative Perpetual Preferred Stock, with liquidation preference of $25.00 per depositary share, subject to market and certain other conditions. The Company expects to grant the underwriters a 30-day

Company expects preliminary estimated revenues to exceed $8.1 million Successor CFO search underway

New Research Findings Published in Pharmaceuticals Identify Novel Peptoids with Potent Antiviral Activity Against HSV-1 and SARS-CoV-2 Antiviral peptoids are being developed by Maxwell Biosciences to treat Recurrent Herpes Labialis

- For her role in using research findings to inform and implement effective public policies promoting better health, the Association for Clinical and Translational Science (ACTS) has awarded Flaura K. Winston

Hillrom (NYSE: HRC) will host its fiscal second quarter 2021 earnings conference call and webcast on Friday, April 30, 2021 , beginning at 7:30 a.m. (CT) / 8:30 a.m. (ET) .

Illumina, Inc. (NASDAQ: ILMN) today announced preliminary revenue for the first quarter of fiscal year 2021 and updated its fiscal year 2021 revenue guidance. Subject to quarter-end closing adjustments, Illumina expects to report first quarter 2021 revenue of approximately $1,085 million, compared to $859 million in the first quarter of 2020.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2021 before the market opens on Thursday, April 29, 2021 , and will hold a conference call on the same day at 8:30 a.m. EDT .

Mesa Laboratories, Inc. announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.